U.S. stocks rise on improved global view Shares of Tiffany

New Post Public Reply Private Reply Replies (0) Message Board
ruliquid

U.S. stocks rise on improved global view
Shares of Tiffany fall sharply after it issues profit warning

NEW YORK (MarketWatch) — U.S. stocks rose on Thursday, lifting the S&P 500 to a five-year closing high, after data from China bolstered the view of an improving global economy.“Chinese growth is accelerating and the market over the last day or so seems to have taken on a more positive tone as it relates to earnings,” said Mark Luschini, chief market strategist at Janney Montgomery Scott.

December exports data from China beat expectations, while European Central Bank President Mario Draghi projected that the euro zone’s economy would bounce back later this year.
http://www.marketwatch.com/story/us-stocks-ri...=afterbell

“In Europe the recession is not worsening, Chinese growth is accelerating and in the U.S., the worst of the fiscal cliff is behind us. The impact of tax cuts is less than what the CBO initially scored, which has the potential to lift confidence and as a result business spending,” said Luschini.

The Dow Jones Industrial Average (DJI JIA)  gained 80.71 points, or 0.6%, to 13,471.22.

Bank of America Corp. (NYSE:BAC) led blue-chip gains, which included 25 of the Dow’s 30 components.

Banks and other financial companies have drawn support this week as the government’s consumer finance watchdog on Thursday unveiled mortgage rules that will make banks use new standards to determine if a borrower has the ability to repay a mortgage. And several large home-loan providers earlier in the week came to an accord with regulators to close a review of foreclosures ordered by the government.

Five days after closing at its highest level since December 2007, the S&P 500 cleared its five-year closing high of 1,466.47.

The S&P 500 (SNC:SPX)  added 11.10 points, or 0.8%, to 1,472.12, with financials leading sector gains among its 10 major industry groups. Financial stocks: Wells Fargo shares rise on eve of results.

Microsoft Corp. (NASDAQ:MSFT)  fell 0.9% after Morgan Stanley downgraded the globe’s biggest software manufacturer to equalweight from underweight.

Tiffany & Co. (NYSE:TIF) reported holiday-season sales that hinted the luxury retailer’s rapid growth of recent years was languishing in the United States, Europe and Japan. The company projected annual earnings at the low end of its prior guidance. Shares of Tiffany shed 4.5%. Read: Tiffany sparkle fades.

“Especially with earnings season beginning, we’re much more focused on stock-specific reports,” said Dan Greenhaus, chief global strategist at BTIG LLC.

After falling into the red, the Nasdaq Composite (NASDAQ:COMP) recouped to end at 3,121.76, up 15.95 points, or 0.5%.

Shares of Apple Inc. (NASDAQ:AAPL)  rose 1.2%. The Wall Street Journal reported that Apple CEO Tim Cook recently met with the chairman of China Mobile, triggering speculation that the mobile carrier may soon be offering the iPhone. Read: China Mobile chairman, Apple CEO talk cooperation.

Also read a commentary piece: Last stand for Apple bulls?

For every stock falling nearly two gained on the New York Stock Exchange, where 727 million shares traded.

Composite volume exceeded 4 billion.

“The jobs data was benign, and the wholesale data nobody cares about,” said Greenhaus of U.S. economic reports, which had inventories at U.S. wholesalers up 0.6% in November and new applications for jobless benefits rising slightly last week. However, the level of jobless claims revealed little change over the past few months and was consistent with a modestly improving U.S. labor market. See: Jobless claims rise to 371,000.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading